{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:44:08Z","timestamp":1786373048589,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.2215\/cjn.01510209","type":"journal-article","created":{"date-parts":[[2009,9,25]],"date-time":"2009-09-25T09:00:29Z","timestamp":1253869229000},"page":"1747-1753","source":"Crossref","is-referenced-by-count":34,"title":["Dystroglycan in the Diagnosis of FSGS"],"prefix":"10.2215","volume":"4","author":[{"given":"Giovanna","family":"Giannico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haichun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric G.","family":"Neilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes B.","family":"Fogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20230601","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/j.ajkd.2003.10.024","article-title":"Pathologic classification of focal segmental glomerulosclerosis: A working proposal","volume":"43","author":"D'Agati","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R2-16-20230601","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/ng.226","article-title":"MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis","volume":"40","author":"Kopp","year":"2008","journal-title":"Nat Genet"},{"key":"R3-16-20230601","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/ndt\/17.suppl_9.23","article-title":"Is podocyte shape controlled by the dystroglycan complex?","volume":"17","author":"Kojima","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"R4-16-20230601","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0092-8674(94)90052-3","article-title":"Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor","volume":"77","author":"Gee","year":"1994","journal-title":"Cell"},{"key":"R5-16-20230601","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0896-6273(94)90462-6","article-title":"Dystroglycan binds nerve and muscle agrin","volume":"13","author":"Sugiyama","year":"1994","journal-title":"Neuron"},{"key":"R6-16-20230601","doi-asserted-by":"crossref","first-page":"23418","DOI":"10.1074\/jbc.271.38.23418","article-title":"Dystroglycan is a dual receptor for agrin and laminin-2 in Schwann cell membrane","volume":"271","author":"Yamada","year":"1996","journal-title":"J Biol Chem"},{"key":"R7-16-20230601","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1074\/jbc.273.1.600","article-title":"Agrin is a high-affinity binding protein of dystroglycan in non-muscle tissue","volume":"273","author":"Gesemann","year":"1998","journal-title":"J Biol Chem"},{"key":"R8-16-20230601","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S1097-2765(00)80388-3","article-title":"The crystal structure of a laminin G-like module reveals the molecular basis of alpha-dystroglycan binding to laminins, perlecan, and agrin","volume":"4","author":"Hohenester","year":"1999","journal-title":"Mol Cell"},{"key":"R9-16-20230601","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0945-053X(00)00072-X","article-title":"Structure and function of laminin LG modules","volume":"19","author":"Timpl","year":"2000","journal-title":"Matrix Biol"},{"key":"R10-16-20230601","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0002-9440(10)65046-8","article-title":"Expression of agrin, dystroglycan, and utrophin in normal renal tissue and in experimental glomerulopathies","volume":"156","author":"Raats","year":"2000","journal-title":"Am J Pathol"},{"key":"R11-16-20230601","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0898-6568(01)00236-4","article-title":"The WW domain: Linking cell signalling to the membrane cytoskeleton","volume":"14","author":"Ilsley","year":"2002","journal-title":"Cell Signal"},{"key":"R12-16-20230601","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1681\/ASN.V113403","article-title":"Glomerular expression of dystroglycans is reduced in minimal change nephrosis but not in focal segmental glomerulosclerosis","volume":"11","author":"Regele","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"R13-16-20230601","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1097\/01.ASN.0000133531.43177.21","article-title":"Podocyte flattening and disorder of glomerular basement membrane are associated with splitting of dystroglycan-matrix interaction","volume":"15","author":"Kojima","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R14-16-20230601","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/0092-8674(93)90515-R","article-title":"WT-1 is required for early kidney development","volume":"74","author":"Kreidberg","year":"1993","journal-title":"Cell"},{"key":"R15-16-20230601","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1007\/s00467-006-0208-1","article-title":"WT1 and glomerular diseases","volume":"21","author":"Niaudet","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"R16-16-20230601","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1681\/ASN.V10151","article-title":"The dysregulated podocyte phenotype: A novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"10","author":"Barisoni","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R17-16-20230601","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/ncpneph0093","article-title":"Mechanisms of disease: Fibroblasts\u2014a new look at an old problem","volume":"2","author":"Neilson","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"R18-16-20230601","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/ki.1990.175","article-title":"Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis","volume":"38","author":"Fogo","year":"1990","journal-title":"Kidney Int"},{"key":"R19-16-20230601","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/sj.ki.5002553","article-title":"Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome: Workshop recommendations","volume":"72","author":"Cattran","year":"2007","journal-title":"Kidney Int"},{"key":"R21-16-20230601","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0022-3476(84)80479-5","article-title":"A simple estimate of glomerular filtration rate in full-term infants during the first year of life","volume":"104","author":"Schwartz","year":"1984","journal-title":"J Pediatr"},{"key":"R22-16-20230601","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/sj.ki.5000160","article-title":"Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants","volume":"69","author":"Thomas","year":"2006","journal-title":"Kidney Int"},{"key":"R23-16-20230601","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/sj.ki.5001903","article-title":"Cellular focal segmental glomerulosclerosis: Clinical and pathologic features","volume":"70","author":"Stokes","year":"2006","journal-title":"Kidney Int"},{"key":"R24-16-20230601","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1523-1755.2000.00152.x","article-title":"HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy","volume":"58","author":"Barisoni","year":"2000","journal-title":"Kidney Int"},{"key":"R25-16-20230601","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1681\/ASN.2007121365","article-title":"Fidelity and evolution of recurrent FSGS in renal allografts","volume":"19","author":"Ijpelaar","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R26-16-20230601","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1097\/01.ASN.0000090745.85482.06","article-title":"Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases","volume":"14","author":"Schmid","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R27-16-20230601","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1111\/j.1523-1755.2004.00563.x","article-title":"Glomerular tip lesion: A distinct entity within the minimal change disease\/focal segmental glomerulosclerosis spectrum","volume":"65","author":"Stokes","year":"2004","journal-title":"Kidney Int"},{"key":"R28-16-20230601","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1523-1755.2005.00500.x","article-title":"Fibroblast-specific protein 1 is a prognostic marker for renal survival in patients with IgA nephropathy","volume":"68","author":"Nishitani","year":"2005","journal-title":"Kidney Int"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-200911000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:41:36Z","timestamp":1786369296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-200911000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.01510209","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}